GlassScriptPhysician profile
Michelle Scott
NPI 1770108813
$4,394.57
in general payments reported to CMS, 2019-2025
19 companies · $530 in 2025
The $530 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.51 · 2022: $698 · 2023: $1,714 · 2024: $1,379 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,596 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,595.64 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,208.94 | 2021-2025 | |
| Axsome Therapeutics, INC. | $743.60 | 2023-2025 | Auvelity |
| Alkermes, INC. | $578.94 | 2021-2024 | Lybalvi, Aristada, Vivitrol |
| Neurocrine Biosciences, INC. | $207.84 | 2021-2023 | Ingrezza |
| Gilead Sciences, INC. | $124.06 | 2024 | Epclusa |
| E.R. Squibb & Sons, L.L.C. | $94.98 | 2024-2025 | Cobenfy |
| Indivior INC. | $86.50 | 2023-2024 | Sublocade |
| Bayer Healthcare Pharmaceuticals INC. | $55.60 | 2022 | |
| Braeburn INC. | $51.84 | 2023 | Brixadi |
| Otsuka America Pharmaceutical, INC. | $49.15 | 2024-2025 | Abilify Maintena, Abilify Asimtufii |
| Masimo Corporation | $37.19 | 2023 | Bridge |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.18 | 2022-2023 | Xifaxan |
| Amgen INC. | $24.25 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $19.54 | 2022 | |
| Lundbeck LLC | $17.99 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $17.85 | 2022 | |
| Merck Sharp & Dohme LLC | $16.50 | 2022 | |
| Lilly USA, LLC | $16.00 | 2022 | |
| Sanofi Pasteur INC. | $13.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.